Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AIRS
Fairly valued
Airsculpt Technologies, Inc.
Price$1.66
Model IV$1.61
P/IV1.57
Premium +3%
Return to IV: -2.9%
Market implies +3.3%/yr
vs model +3.3% · in line
AUNA
Valuation N/A
AUNA S.A.
Price$5.10
Model IV—
P/IV—
Limited data — see page
BMGL
Valuation N/A
Basel Medical Group Ltd
Price$3.60
Model IV—
P/IV—
Market implies +35.7%/yr
CCM
Valuation N/A
Concord Medical Services Holdings Ltd
Price$3.10
Model IV—
P/IV—
Market implies +11.2%/yr
vs model +2.0% · above model
HIMS
Undervalued
Hims & Hers Health, Inc.
Price$28.06
Model IV$39.25
P/IV0.67
Discount 29%
Return to IV: +39.9%
Market implies +0.9%/yr
vs model +50.0% · below model
LFMD
Deeply undervalued
LifeMD, Inc.
Price$2.65
Model IV$5.34
P/IV0.80
Discount 50%
Return to IV: +101.4%
Market implies -9.4%/yr
vs model +20.2% · below model
LFMDP
Deeply overvalued
LifeMD, Inc.
Price$22.36
Model IV$13.88
P/IV1.67
Premium +61%
Return to IV: -37.9%
Market implies +2.1%/yr
vs model +20.2% · below model
SBC
Deeply overvalued
SBC Medical Group Holdings Inc
Price$5.34
Model IV$3.79
P/IV1.28
Premium +41%
Return to IV: -29.1%
Market implies +8.2%/yr
vs model +5.4% · in line
SBCWW
Deeply undervalued
SBC Medical Group Holdings Inc
Price$0.42
Model IV$1.76
P/IV0.20
Discount 76%
Return to IV: +319.6%
Market implies -28.9%/yr
vs model +2.0% · below model
TDOC
Deeply undervalued
Teladoc Health, Inc.
Price$5.54
Model IV$13.49
P/IV0.56
Discount 59%
Return to IV: +143.6%
Market implies -9.3%/yr
vs model +6.9% · below model
TOI
Deeply undervalued
Oncology Institute, Inc.
Price$6.20
Model IV$10.83
P/IV0.43
Discount 43%
Return to IV: +74.6%
Market implies -7.6%/yr
vs model +25.5% · below model
TOIIW
Valuation N/A
TOIIW
Price$0.05
Model IV—
P/IV—
Limited data — see page